Market Overview:
The global IVD products market is expected to grow at a CAGR of 6.5% during the forecast period 2018-2030. The market growth can be attributed to the increasing incidence of chronic diseases, rising demand for personalized medicine, and technological advancements in the field of diagnostics. The global IVD products market is segmented on the basis of type into immunodiagnostics, molecular diagnostics, tissue diagnostics, and others. Immunodiagnostics accounted for the largest share in 2017 and is expected to maintain its dominance during the forecast period owing to increasing demand for point-of-care testing (POCT) devices. Molecular diagnostics is projected to grow at a highest CAGR during 2018-2030 due to its growing application in cancer diagnosis and prenatal screening. On the basis of application, hospitals accounted for majority share in 2017 followed by laboratories and research & academic institutions respectively.
Product Definition:
IVD products are used to detect and diagnose diseases or conditions. They can also be used to monitor the effectiveness of treatments. IVD products play an important role in healthcare, as they allow for early detection and treatment of diseases.
Immuno Diagnostics:
The global immuno diagnostics, it's usage and growth factor in IVD (In Vitro Diagnostics) Products market size was valued at USD 4.5 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period. The rising prevalence of chronic diseases such as cancer, diabetes, autoimmune disorders & other infectious diseases are anticipated to boost demand for immuno-diagnostics products thereby influencing industry growth over the forecast period.
Molecular Diagnostics:
Molecular diagnostics is a set of procedures used to identify and analyze genetic elements in an individual. It also helps in determining the cause of various diseases and disorders. These tests are performed by laboratories, physicians, or other healthcare professionals using various techniques such as PCR (polymerase chain reaction), DNA sequencing, etc. Molecular diagnostic tests are used for the diagnosis of cancer; infectious diseases; cardiovascular disease; diabetes mellitus; etc.
Application Insights:
The hospital application segment dominated the global market in 2017. The growth of this segment can be attributed to the increasing prevalence of chronic diseases and rising number of surgeries. A large number of players are focusing on enhancing their product portfolio for IVD kits that are used in hospitals for diagnosing various diseases efficiently. For instance, Roche offers full range diagnostic solutions that enable healthcare professionals to deliver precise diagnoses with greater efficiency and accuracy at a lower cost than ever before.
Rising demand for point-of-care testing across several applications such as laboratories, hospitals, clinics and others is expected to boost revenue generation over the forecast period. In addition, growing investments by governments & private institutions in developing advanced diagnostic technologies are anticipated to further fuel industry expansion over the coming years (8% CAGR). Increasing R&D activities pertaining towards advance IVF techniques is also projecteded drive demand over next eight years (0% CAGR).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high adoption rate of advanced technologies, and rising demand for point-of-care (PoC) diagnostic products. The U.S., which is at the forefront of this region, has been witnessing a significant increase in healthcare spending owing to an increasing number of chronic diseases that require regular monitoring and timely treatment.
Growth Factors:
- Increasing incidence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. This has led to a surge in demand for diagnostic tests, which in turn is benefiting the IVD products market.
- Technological advancements: The IVD products market is witnessing rapid technological advancements, with new and innovative products being launched regularly. This is helping to boost demand for these products, as they offer better accuracy and reliability than traditional methods.
- Rising awareness about preventive healthcare: There has been a growing awareness among people about the importance of preventive healthcare measures in order to stay healthy and avoid serious illnesses later in life. This has led to an increase in demand for diagnostic tests, which are essential for early diagnosis and treatment of various health conditions.
Scope Of The Report
Report Attributes
Report Details
Report Title
IVD (In Vitro Diagnostics) Products Market Research Report
By Type
Immuno Diagnostics, Molecular Diagnostics, Tissue Diagnostics, Others
By Application
Hospital, Laboratories, Research & Academic, Others
By Companies
Thermo Fisher Scientific, Roche Diagnostics, Abbott Laboratories, Becton Dickinson, BioMérieuxSA, Immucor, Illumina, Luminex Corporation, CareDx, Hologic, GenDx, Biofortuna, QIAGEN NV, Bio-Rad Laboratories
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global IVD (In Vitro Diagnostics) Products Market Report Segments:
The global IVD (In Vitro Diagnostics) Products market is segmented on the basis of:
Types
Immuno Diagnostics, Molecular Diagnostics, Tissue Diagnostics, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Laboratories, Research & Academic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher Scientific
- Roche Diagnostics
- Abbott Laboratories
- Becton Dickinson
- BioMérieuxSA
- Immucor
- Illumina
- Luminex Corporation
- CareDx
- Hologic
- GenDx
- Biofortuna
- QIAGEN NV
- Bio-Rad Laboratories
Highlights of The IVD (In Vitro Diagnostics) Products Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Immuno Diagnostics
- Molecular Diagnostics
- Tissue Diagnostics
- Others
- By Application:
- Hospital
- Laboratories
- Research & Academic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the IVD (In Vitro Diagnostics) Products Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
IVD products are diagnostic tests that are performed in vitro, meaning outside of the body. IVD tests can be used to diagnose a variety of medical conditions, including cancer and heart disease.
Some of the major companies in the ivd (in vitro diagnostics) products market are Thermo Fisher Scientific, Roche Diagnostics, Abbott Laboratories, Becton Dickinson, BioM©rieuxSA, Immucor, Illumina, Luminex Corporation, CareDx, Hologic, GenDx, Biofortuna, QIAGEN NV, Bio-Rad Laboratories.
The ivd (in vitro diagnostics) products market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 IVD (In Vitro Diagnostics) Products Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 IVD (In Vitro Diagnostics) Products Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 IVD (In Vitro Diagnostics) Products Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the IVD (In Vitro Diagnostics) Products Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global IVD (In Vitro Diagnostics) Products Market Size & Forecast, 2018-2028 4.5.1 IVD (In Vitro Diagnostics) Products Market Size and Y-o-Y Growth 4.5.2 IVD (In Vitro Diagnostics) Products Market Absolute $ Opportunity
Chapter 5 Global IVD (In Vitro Diagnostics) Products Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 IVD (In Vitro Diagnostics) Products Market Size Forecast by Type
5.2.1 Immuno Diagnostics
5.2.2 Molecular Diagnostics
5.2.3 Tissue Diagnostics
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global IVD (In Vitro Diagnostics) Products Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 IVD (In Vitro Diagnostics) Products Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Laboratories
6.2.3 Research & Academic
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global IVD (In Vitro Diagnostics) Products Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 IVD (In Vitro Diagnostics) Products Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America IVD (In Vitro Diagnostics) Products Analysis and Forecast
9.1 Introduction
9.2 North America IVD (In Vitro Diagnostics) Products Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America IVD (In Vitro Diagnostics) Products Market Size Forecast by Type
9.6.1 Immuno Diagnostics
9.6.2 Molecular Diagnostics
9.6.3 Tissue Diagnostics
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America IVD (In Vitro Diagnostics) Products Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Laboratories
9.10.3 Research & Academic
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe IVD (In Vitro Diagnostics) Products Analysis and Forecast
10.1 Introduction
10.2 Europe IVD (In Vitro Diagnostics) Products Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe IVD (In Vitro Diagnostics) Products Market Size Forecast by Type
10.6.1 Immuno Diagnostics
10.6.2 Molecular Diagnostics
10.6.3 Tissue Diagnostics
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe IVD (In Vitro Diagnostics) Products Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Laboratories
10.10.3 Research & Academic
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific IVD (In Vitro Diagnostics) Products Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific IVD (In Vitro Diagnostics) Products Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific IVD (In Vitro Diagnostics) Products Market Size Forecast by Type
11.6.1 Immuno Diagnostics
11.6.2 Molecular Diagnostics
11.6.3 Tissue Diagnostics
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific IVD (In Vitro Diagnostics) Products Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Laboratories
11.10.3 Research & Academic
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America IVD (In Vitro Diagnostics) Products Analysis and Forecast
12.1 Introduction
12.2 Latin America IVD (In Vitro Diagnostics) Products Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America IVD (In Vitro Diagnostics) Products Market Size Forecast by Type
12.6.1 Immuno Diagnostics
12.6.2 Molecular Diagnostics
12.6.3 Tissue Diagnostics
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America IVD (In Vitro Diagnostics) Products Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Laboratories
12.10.3 Research & Academic
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) IVD (In Vitro Diagnostics) Products Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) IVD (In Vitro Diagnostics) Products Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) IVD (In Vitro Diagnostics) Products Market Size Forecast by Type
13.6.1 Immuno Diagnostics
13.6.2 Molecular Diagnostics
13.6.3 Tissue Diagnostics
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) IVD (In Vitro Diagnostics) Products Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Laboratories
13.10.3 Research & Academic
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 IVD (In Vitro Diagnostics) Products Market: Competitive Dashboard
14.2 Global IVD (In Vitro Diagnostics) Products Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Thermo Fisher Scientific
14.3.2 Roche Diagnostics
14.3.3 Abbott Laboratories
14.3.4 Becton Dickinson
14.3.5 BioMérieuxSA
14.3.6 Immucor
14.3.7 Illumina
14.3.8 Luminex Corporation
14.3.9 CareDx
14.3.10 Hologic
14.3.11 GenDx
14.3.12 Biofortuna
14.3.13 QIAGEN NV
14.3.14 Bio-Rad Laboratories